Kevin C. Gorman
2016
In 2016, Kevin C. Gorman earned a total compensation of $5.3M as President and Chief Executive Officer at Neurocrine Biosciences, a 6% increase compared to previous year.
Compensation breakdown
| Bonus | $337,440 |
|---|---|
| Option Awards | $2,202,729 |
| Salary | $592,000 |
| Stock Awards | $2,114,413 |
| Other | $43,076 |
| Total | $5,289,658 |
Gorman received $2.2M in option awards, accounting for 42% of the total pay in 2016.
Gorman also received $337.4K in bonus, $592K in salary, $2.1M in stock awards and $43.1K in other compensation.
Rankings
In 2016, Kevin C. Gorman's compensation ranked 1,485th out of 14,075 executives tracked by ExecPay. In other words, Gorman earned more than 89.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,485 out of 14,075 | 89th |
Division Manufacturing | 509 out of 5,488 | 91st |
Major group Chemicals And Allied Products | 142 out of 1,900 | 93rd |
Industry group Drugs | 97 out of 1,543 | 94th |
Industry Biological Products, Except Diagnostic Substances | 19 out of 287 | 93rd |
Source: SEC filing on April 20, 2017.
Gorman's colleagues
We found five more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2016.
2016
Timothy Coughlin
Neurocrine Biosciences
Chief Financial Officer
2016
Christopher O'Brien
Neurocrine Biosciences
Chief Medical Officer
2016
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
2016
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
2016
Kyle Gano
Neurocrine Biosciences
Chief Business Development Officer
News
Neurocrine Biosciences CEO Kevin Gorman's 2021 pay rises 1% to $14M
April 7, 2022
Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M
April 9, 2021
Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M
April 9, 2020
Neurocrine Biosciences CEO Kevin Gorman's 2018 pay rises 14% to $8.6M
April 17, 2019